Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Rosenblatt Maintains Neutral on Datadog, Raises Price Target to $150

Rosenblatt analyst Blair Abernethy maintains Datadog (NASDAQ:DDOG) with a Neutral and raises the price target from $120 to $150.

byBenzinga Newsdesk

October 29, 2021

1 minute read

Rosenblatt analyst Blair Abernethy maintains Datadog (NASDAQ:DDOG) with a Neutral and raises the price target from $120 to $150.

News

ANI Pharmaceuticals Announces Commercial Availability Of Purified Cortrophin Gel For Multiple Chronic Autoimmune Disorders

By Benzinga Newsdesk

Today, 10:55 PM

ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) (ANI or the Company) today announced the U.S. commercial availability of Purified Cortrophin™ Gel (Repository Corticotropin Injection USP) 80 U/mL. The commercial launch of

ANIP

Prelude Therapeutics Q3 EPS $(0.63) Up From $(0.66) YoY

By Benzinga Newsdesk

Today, 10:55 PM

Prelude Therapeutics (NASDAQ:PRLD) reported quarterly losses of $(0.63) per share. This is a 4.55 percent increase over losses of $(0.66) per share from the same period last year.

PRLD